Blueprint Medicines (NASDAQ:BPMC) Price Target Raised to $119.00
otakuyassine3@gmail.com Blueprint Medicines (NASDAQ:BPMC – Free Report) had its target price boosted by Piper Sandler from...
Blueprint
Blueprint Medicines’ (BPMC) Outperform Rating Reiterated at Wedbush
Wedbush reaffirmed their outperform rating on shares of Blueprint Medicines (NASDAQ:BPMC – Free Report) in...